Fund moves

Tenet Health (THC): Farallon Capital Management, L.L.C. reduced its stake -42K shares

Farallon Capital Management, L.L.C. reduced its stake in Tenet Health, per its Q4 2025 13F.

372K
Shares reported · -42K vs prior quarter
0.34%
Disclosed portfolio weight
$74M
Reported value
Holdings as of
Dec 31, 2025
Filed
May 15, 2026

What stands out in this filing

  • 414,000 shares in Q3 2025, 372,153 now (−10.1% in share count).
  • Reported at $74M, 0.34% of the portfolio value in this 13F filing.
  • 20 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 25, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 25, 2026 , the Company appointed J. Michael Grooms, age 48, Senior Vice President & Controller of the Company, effective April 6, 2026. Mr. Grooms will succeed Mr. Ramsey as the Company’s Principal Accounting Officer effective May 1, 2026, following the effective date of Mr. Ramsey’s retirement.”
  2. Mar 31, 2026Federal contract · $350K obligatedDepartment of Defense awarded TENET HEALTHCARE CORP: $350K obligated to date
  3. Apr 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 9, 2026 , Tenet Healthcare Corporation (the “Company”) and Paola Arbour entered into a Retirement Transition Agreement and General Release (the “Agreement”) that provides that Ms. Arbour will retire from her role as Executive Vice President and Chief Information Officer effective December 31, 2026, but will remain employed on a part-time basis in a non-executive role through April 1, 2028 to provide…”
  4. Apr 15, 2026CongressDisclosed sale of THC — reported range $1,001 - $15,000
  5. Apr 20, 2026CongressDisclosed sale of THC — reported range $15,001 - $50,000
  6. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. May 27, 2026InsiderDirector sold ~$532K of THC shares in the open market
  2. May 28, 2026Insider · 1 personInsiders: 5 sales (~$984K)
  3. May 29, 2026Federal contract · $350K obligatedDepartment of Defense awarded TENET HEALTHCARE CORP: $350K obligated to date
  4. Jun 12, 2026Federal contract · $135K obligatedDepartment of Veterans Affairs awarded TENET HEALTHCARE CORP: $135K obligated to date
  5. Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
  6. Jul 27, 2026Insider · 3 peopleInsiders: 3 sales (~$4.8M)
  7. Jul 29, 2026Insider · Their largest sale since 2024Officer sold ~$2.58M of THC shares in the open market
  8. Aug 5, 2026InsiderDirector sold ~$158K of THC shares in the open market
  9. Aug 6, 2026InsiderDirector sold ~$1.3M of THC shares in the open market
  10. Aug 7, 2026InsiderDirector sold ~$652K of THC shares in the open market
  11. Aug 24, 2026Insider · 2 peopleInsiders: 3 sales (~$14.3M)
  12. Aug 25, 2026Insider · 1 personInsiders: 3 sales (~$13.7M)
  13. Aug 31, 2026Insider · Their largest sale since 2024Officer sold ~$6.39M of THC shares in the open market
  14. Sep 2, 2026InsiderDirector sold ~$298K of THC shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Tenet Health

For Tenet Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its THC page.

How this filing works

Explore the data

Common questions

What does this filing report about Tenet Health (THC) stock?

Farallon Capital Management, L.L.C. reduced its stake in Tenet Health, per its Q4 2025 13F. Now 372K shares, $74M reported value, 0.34% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: May 15, 2026.

What stands out in this filing?

414,000 shares in Q3 2025, 372,153 now (−10.1% in share count). Reported at $74M, 0.34% of the portfolio value in this 13F filing. 20 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Tenet Health recently?

For Tenet Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the THC page.

Does this mean THC stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tenet Health

Everything OQRO holds on this company is on its THC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data